COVID-19 vaccines have been approved for use early in 2021, with the BioNTech mRNA vaccine (Comirnaty®) being one of the first vaccines made widely available in the market. The BNT162b2 vaccine, which carries a nucleoside-modified messenger RNA encoding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein, produces a high serum neutralising antibody titre and antigen-specific T-cell response when administered in two 30µg doses in healthy adults.
Tag Archive for: vaccine
https://medi-paper.com/wp-content/uploads/2021/11/Pfizer-BioNTech-COVID-19-Vaccine-for-Ages-5-to-11-Years.jpg 1024 1917 Catalina FOK https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Catalina FOK2021-11-03 15:29:572022-01-07 14:26:23BioNTech COVID-19 vaccine for ages 5 to 11 years – To jab or not to jab?
MediPR | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | Medical Writer Jobs | PMHub